BlueWillow Biologics demonstrated the safety and immunogenicity in humans of the company’s intranasal technology, which CEO Chad Costley said is the only adjuvanted intranasal platform that is not virus-based.
Scientists who mapped the DNA of the New York City subway system have backed off a claim that they discovered traces of anthrax and bubonic plague at several stations, after […]